Atlas Trials

A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT03482050 · COMPLETED

Trial details

NCT number
NCT03482050
Sponsor
Kadimastem
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ALS (Amyotrophic Lateral Sclerosis)
Start date
2018-04-12
Primary completion
2020-06-22
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.